NCT01138462

Brief Summary

The purpose of this study is to determine the better approach between the currently procedure (i.e. standards precautions) and a reinforced strategy to control MRSA transmission in the institutionalized population of nursing homes in Canton of Vaud, Switzerland.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2010

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

June 4, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 7, 2010

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

March 30, 2020

Status Verified

March 1, 2020

Enrollment Period

1.5 years

First QC Date

June 4, 2010

Last Update Submit

March 26, 2020

Conditions

Keywords

Methicillin-Resistant Staphylococcus aureusDecolonisationNursing homesInfection Control

Outcome Measures

Primary Outcomes (1)

  • To determine the change in prevalence of MRSA carriage among residents of each Nursing homes group at the end of the one study year

    in each control and intervention nursing home: MRSA screening of all residents of nursing homes of Canton Vaud, at baseline and 1 year later, in order to compare MRSA prevalence changes at nursing homes levels

    1 year

Secondary Outcomes (1)

  • To determine the effectiveness of the reinforced strategy to prevent MRSA infection, compared to the standard strategy

    1 year

Study Arms (2)

Standard Precautions

NO INTERVENTION

control arm, standards precautions for all residents living in the nursing home of control arm, including MRSA carriers

Intervention

OTHER

Intervention arm, standards precautions for all residents living in nursing homes of intervention arm, and topical decolonization for MRSA carriers, including environmental disinfection

Other: intervention

Interventions

5 days topical decolonisation including nasal mupirocin tid, chlorhexidine mouth wash tid, chlorhexidine body wash once daily. Daily direct resident's environmental disinfection during decolonisation.

Also known as: topical MRSA decolonisation and environmental disinfection
Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all nursing homes of canton Vaud, Switzerland, that give the consent of participation

You may not qualify if:

  • \- refusal to participate
  • \- all MRSA positive residents living in a Nursing Home included in the intervention group
  • residents that refuse to be screened or refused the decolonisation
  • life expectancy shorter of 7 days
  • known intolerance of disinfectant/ topical antibiotics used in the protocol
  • active MRSA infection
  • asymptomatic MRSA bacteriuria
  • stage IV wound (according to National Pressure Ulcer Advisory Panel)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Bellini C, Petignat C, Masserey E, Bula C, Burnand B, Rousson V, Blanc DS, Zanetti G. Universal screening and decolonization for control of MRSA in nursing homes: a cluster randomized controlled study. Infect Control Hosp Epidemiol. 2015 Apr;36(4):401-8. doi: 10.1017/ice.2014.74.

    PMID: 25782894BACKGROUND

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Giorgio Zanetti, MD

    University Hospital of Lausanne, Switzerland

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 4, 2010

First Posted

June 7, 2010

Study Start

June 1, 2010

Primary Completion

December 1, 2011

Study Completion

December 1, 2011

Last Updated

March 30, 2020

Record last verified: 2020-03